• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT? PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911632220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Death (1802); Myocardial Infarction (1969); Renal Failure (2041); Shock (2072); Respiratory Failure (2484)
Event Date 02/07/2014
Event Type  Death  
Event Description
Same case as mdr id: 2134265-2015-00514; 2134265-2015-00515 and 2134265-2015-00517.(b)(4).It was reported that acute respiratory failure and death occurred.In october 2012, the patient was referred for cardiac catheterization.Subsequently, coronary angiography the index procedure were performed.The target lesion # 1 was a de novo lesion located in the right posterior descending artery (r-pda) with 80% stenosis and was 10 mm long with a reference vessel diameter of 2.25 mm.The lesion was treated with direct placement of a 2.25 mm x 12 mm promus element¿ plus stent, resulting to 0% residual stenosis.Target lesion # 2 was a de novo lesion located in the mid right coronary artery (rca) with 80% stenosis and was 10 mm long with a reference vessel diameter of 2.25 mm.The lesion was treated with direct placement of a 2.25 mm x 12 mm promus element¿ plus stent, resulting to 0% residual stenosis.The target lesion # 3 was a de novo lesion located in the proximal rca with 90% stenosis and was 28 mm long with a reference vessel diameter of 2.25 mm.The lesion was treated with direct placement of a 2.25 mm x 32 mm promus element¿ plus stent, resulting to 0% residual stenosis.Target lesion # 4 was a de novo lesion located in the 1st obtuse marginal (om) with 80% stenosis and was 10 mm long with a reference vessel diameter of 2.5 mm.The lesion was treated with direct placement of a 2.50 mm x 12 mm promus element¿ plus stent, resulting to 0% residual stenosis.One day post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2014, the patient presented emergently with acute respiratory failure, diabetic ketoacidosis, shock, non st elevation myocardial infarction (nstemi) (status post cardiac arrest and resuscitation en route), and renal failure.The patient had not taken insulin for 2 days and the patient was already intubated for assisted ventilation on arrival to emergency room (er).Computed tomography (ct) scan of the head revealed cerebral edema but no acute process.Patient's prognosis was poor.The patient was then treated aggressively with fluids and medications, including advanced cardiac life support (acls) measures, until family produced documentation of legal power of attorney/healthcare proxy.On the following day, after verification of patient's wishes, aggressive therapy was discontinued in favor of comfort care measures only.Subsequently, the patient expired.Death certificate is not available and autopsy was not performed.The primary cause of death was acute respiratory failure.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the complaint device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT? PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4487467
MDR Text Key5328434
Report Number2134265-2015-00516
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/05/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/28/2012
Device Model NumberH7493911632220
Device Catalogue Number39116-3222
Device Lot Number14940929
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/21/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/20/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age55 YR
-
-